Manulife (Manufacturers Life Insurance)’s Burning Rock Biotech BNR Stock Holding History

Manulife (Manufacturers Life Insurance)’s Portfolio BNR Stock Details BNR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-3,891	Closed	-$84.4K	–	2938
2022 Q4	$84.4K	Hold	3,891	–	–	﹤0.01%	2834
2022 Q3	$93.4K	Hold	3,891	–	–	﹤0.01%	2830
2022 Q2	$105K	Hold	3,891	–	–	﹤0.01%	2892
2022 Q1	$375K	Buy	+3,891	New	+$338K	﹤0.01%	2366
2021 Q3	–	Sell	-730	Closed	-$215K	–	3153
2021 Q2	$215K	Buy	+730	New	+$216K	﹤0.01%	3058

Other funds holding BNR

KCM

Kynam Capital Management Princeton, New Jersey $1.62B AUM 138.67% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return

Fidelity International Hamilton, Bermuda $129B AUM 30.83% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return

NAMA

Nikko Asset Management Americas New York $7.07B AUM 50.91% 1-Year Est. Return

Barclays London, United Kingdom $416B AUM 33.63% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Manulife (Manufacturers Life Insurance)'s BNR Position: Q1 2023 in Review

Manulife (Manufacturers Life Insurance) sold out of Burning Rock Biotech (BNR) in Q1 2023, closing a stake of 3,891 shares — an estimated $84.4K sold.

Manulife (Manufacturers Life Insurance) first reported a position in BNR in Q2 2021 and held it in 5 quarters. The position peaked at $375K in Q1 2022. 34 funds tracked by Wall St. Rank hold BNR as of Q1 2023.

Manulife (Manufacturers Life Insurance) reported no remaining Burning Rock Biotech position as of Q1 2023 after selling out during the quarter.
Manulife (Manufacturers Life Insurance) sold 3,891 Burning Rock Biotech shares in Q1 2023, an estimated $84.4K.
Manulife (Manufacturers Life Insurance) first reported a position in Burning Rock Biotech in Q2 2021 and held it in 5 quarters.
Manulife (Manufacturers Life Insurance)'s Burning Rock Biotech position peaked at $375K in Q1 2022.
34 funds tracked by Wall St. Rank held Burning Rock Biotech as of Q1 2023.

Based on Manulife (Manufacturers Life Insurance)'s 13F filing for Q1 2023, filed 15 May 2023.